Phibro Animal Health (PAHC) Change in Accured Expenses (2013 - 2026)

Phibro Animal Health's (PAHC) quarterly Change in Accured Expenses came in at $361000.0 in Q1 2026, up 281.41% year-on-year from $94649.5 in Q1 2025, and down 96.73% quarter-over-quarter from $11.0 million in Q4 2025.

Phibro Animal Health (PAHC) Change in Accured Expenses (2013 - 2026) Analysis & Trends

Phibro Animal Health's Change in Accured Expenses history runs 14 years deep, the most recent figure standing at $361000.0 for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 281.41% year-over-year to $361000.0 in Q1 2026; TTM through Mar 2026 was $23.8 million, a 21.48% decrease from a year earlier, with the FY2025 full-year figure at $47.2 million, up 286.9% from the prior year.
  • Change in Accured Expenses declined to $361000.0 in Q1 2026 per PAHC's latest filing, from $11.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $26.1 million in Q2 2025 and bottomed at -$13.7 million in Q3 2025.
  • The 5-year median for Change in Accured Expenses is $361000.0 (2026), against an average of $3.3 million.
  • Across the five-year window, Change in Accured Expenses soared 1357.99% in 2024 and slumped 288.42% in 2025, its largest moves.
  • Year by year, Change in Accured Expenses stood at $6.0 million in 2022, then surged by 36.38% to $8.2 million in 2023, then soared by 202.8% to $24.8 million in 2024, then tumbled by 55.48% to $11.0 million in 2025, then slumped by 96.73% to $361000.0 in 2026.
  • Per Business Quant, the three latest PAHC Change in Accured Expenses figures stand at $361000.0 (Q1 2026), $11.0 million (Q4 2025), and -$13.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Phibro Animal Health 1.43 Bn 1.35 Bn 125.68 Mn 361,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 361,000.00
Mar 31, 2026 361,000.00
Dec 31, 2025 11.03 Mn
Dec 31, 2025 11.03 Mn
Sep 30, 2025 -13.69 Mn
Sep 30, 2025 -13.69 Mn
Jun 30, 2025 26.12 Mn
Jun 30, 2025 26.12 Mn
Mar 31, 2025 -199,000.00
Mar 31, 2025 -199,000.00
Dec 31, 2024 24.77 Mn
Dec 31, 2024 24.77 Mn
Sep 30, 2024 -3.52 Mn
Sep 30, 2024 -3.52 Mn
Jun 30, 2024 9.28 Mn
Jun 30, 2024 9.28 Mn
Mar 31, 2024 530,000.00
Mar 31, 2024 530,000.00
Dec 31, 2023 8.18 Mn
Dec 31, 2023 8.18 Mn